BDNF and myeloid sarcoma: The main goal of this study was to explore whether or not BDNF levels in MS patients reflect their condition (based on clinical and magnetic resonance imaging variables) with measurements based on a recently developed and validated BDNF ELISA in a large cohort of patients with MS and matched healthy controls.